Global Update on Pneumococcal Disease

Pneumococcal disease is a worldwide public health concern. Although all ages are at risk for invasive pneumococcal disease, mortality is highest at the ends of the age spectrum, disproportionately affecting the very young and older patients. This Clinical Advances will include activities focusing on the awareness and prevention of pneumococcal disease in age groups at special risk, delivered by world-renowned experts in this field.

Mass Gatherings: A "Vector" for Communicable DiseasesDr Kassianos and international experts discuss the risk for communicable diseases at mass gatherings and strategies for prevention.
September 24, 2013
Influenza Season: An Opportunity to Prevent Pneumococcal InfectionDr Kassianos compares seasonal influenza and pneumococcal infection, and presents specific experience with immunization campaigns.
September 10, 2013
Pneumococcal Conjugate Vaccines: Bridging the Age GapDr Pelton discusses the changing epidemiology of pneumococcal disease, and risk factors for the disease in adult patients of all ages.
August 28, 2013

Pneumonia and Other Mucosal Pneumococcal Infections in Children
Dr Dagan and experts review the epidemiology of invasive and noninvasive pneumococcal disease in children and the effects of PCVs.
June 25, 2014

Steering Committee Chair

Ron Dagan, MD
Professor of Pediatrics and Infectious
Diseases, Ben-Gurion University;
Director, Pediatric Infectious Disease Unit
Soroka University Medical Center
Beer-Sheva, Israel

Steering Committee Members

Charles Feldman, MB BCh, DSc, PhD
Professor of Pulmonology and
Chief Physician, Charlotte Maxeke,
Johannesburg Academic Hospital,
University of the Witwatersrand,
Johannesburg, South Africa
Endre J. Ludwig, MD, PhD
Professor, St László Teaching
Hospital, Semmelweis University
Division of Infectology
Budapest, Hungary

Rosana Richtmann, MD, PhD
President, Infectious Disease
Society of São Paulo, Emilio
Ribas Infectious Diseases Institute,
São Paulo, Brazil
Rontgene M. Solante, MD
President, Philippine Society for Microbiology and Infectious Diseases, Quezon City, Philippines; Associate Professor, University of the East Ramon Magsaysay Memorial College, School of Medicine, Quezon City, Philippines; Department Head, Adult Infectious Diseases and Tropical Medicine, San Lazaro Hospital, Manila, Philippines

Disclaimer: This Clinical Advances is intended for an audience of healthcare professionals located outside the United States.

Supported by

Downloadable Slide Kit

Pneumococcal Disease and Immunization in Older Adults: Disease Burden, Risk Groups, Vaccine Strategies, and Overcoming Barriers
Looking at pneumococcal disease in adults 50 years and older, assessing risk, identifying patient and physician barriers to vaccination, and examining the mechanisms of conjugation.
Pediatric Pneumococcal Conjugate Vaccines: Invasive and Noninvasive Pneumococcal Disease, Carriage, and Herd Protection
Examining pneumococcal disease manifestations (from pneumonia and otitis media to invasive disease) and the varied scope of protection afforded by pneumococcal conjugate vaccines.

Clinical Articles

Steering Committee

Ron Dagan, MD

Ron Dagan, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Crucell; GlaxoSmithKline; Merck Sharp & Dohme Corp.; NasVax Ltd.; Novartis Pharmaceuticals Corporation; Pfizer Inc.
Served as a speaker or a member of a speakers bureau for: Crucell; GlaxoSmithKline; Pfizer Inc.
Received grants for clinical research from: Crucell; Merck Sharp & Dohme Corp.; Pfizer Inc.; Protea Vaccine Technologies Ltd.
Owns stock, stock options, or bonds from: NasVax Ltd.; Protea Vaccine Technologies Ltd.

Charles Feldman, MB BCh, DSc, PhD

Charles Feldman, MB BCh, DSc, PhD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: GlaxoSmithKline; Pfizer Inc
Served as a speaker or a member of a speakers bureau for: GlaxoSmithKline; Pfizer Inc

Endre J. Ludwig, MD, PhD

Endre J. Ludwig, MD, PhD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Astellas Pharma, Inc.; Bayer HealthCare Pharmaceuticals; Pfizer Inc
Served as a speaker or a member of a speakers bureau for: Bayer HealthCare Pharmaceuticals; Pfizer Inc

Rosana Richtmann, MD, PhD

Rosana Richtmann, MD, PhD, has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Abbott Laboratories; GlaxoSmithKline; Merck Sharp & Dohme Corp.; Pfizer Inc.

Rontgene M. Solante, MD

Rontgene M. Solante, MD, has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Janssen Pharmaceuticals Products, L.P.; Merck & Co., Inc.; Pfizer Inc; Sanofi